Cost-Effectiveness Analysis of Omalizumab Combined With Standard of Care in Treating Moderate to Severe Asthma Children in China. Cao W, Yu Y, Xiao Y, Morton A, et al. Pediatr Pulmonol 2025;60:e71066.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cao W, Yu Y, Xiao Y, Morton A, et al. Cost-Effectiveness Analysis of Omalizumab Combined With Standard of Care in Treating Moderate to Severe Asthma Children in China. Pediatr Pulmonol 2025;60:e71066.
PMID: 40152080